Issue

Vol. 63 No. 1: Issue 1

The undersigned hereby assign all rights, included but not limited to copyright, for this manuscript to CMB Association upon its submission for consideration to publication on Cellular and Molecular Biology. The rights assigned include, but are not limited to, the sole and exclusive rights to license, sell, subsequently assign, derive, distribute, display and reproduce this manuscript, in whole or in part, in any format, electronic or otherwise, including those in existence at the time this agreement was signed. The authors hereby warrant that they have not granted or assigned, and shall not grant or assign, the aforementioned rights to any other person, firm, organization, or other entity. All rights are automatically restored to authors if this manuscript is not accepted for publication.

Nitric oxide levels in response to the patients with different stage of diabetes

https://doi.org/10.14715/cmb/2017.63.1.10
O. Ozcelik
Firat University, Faculty of Medicine, Department of Physiology
S. Algul
Yuzuncu Yil University, Faculty of Medicine, Department of Physiology

Corresponding Author(s) : S. Algul

serminalgul@hotmail.com

Cellular and Molecular Biology, Vol. 63 No. 1: Issue 1

Abstract

The association between hyperglycaemia and serum nitric oxide (NO) levels has not yet been fully clarified. Thus, it was aimed to evaluate the concentration of NO metabolites (nitrate, nitrite) in diabetic patients and to find the relationship between hyperglycaemia and serum NO levels in diabetic and prediabetic patients, and control groups. In this study, 100 subjects were divided into 3 groups: healthy control (n=20), prediabetic (n=40) and diabetic (n=40). Glycemic control was assessed using glycated hemoglobin (HbA1c). Nitrate and nitrite levels were measured using the Griess reagent. NO was obtained from the sum of nitrates and nitrites. The serum NO level was higher in diabetic (53.4±2.0 μM) and prediabetic patients (51.6±1.6 μM) as compared to that in the control (45.6±1.2 μM), (p<0.05). The NO level was not significantly different in diabetic and prediabetic patients. Higher levels of serum glucose, insulin and HOMA-IR may be responsible for the activation of endothelial cells to increase NO levels. This study supports the role of insulin resistance in increased NO levels in both diabetic and prediabetic patients.

Keywords

Nitric oxide Diabetes Prediabetes Hyperglycaemia Endothelial dysfunction.
Ozcelik, O., & Algul, S. (2017). Nitric oxide levels in response to the patients with different stage of diabetes. Cellular and Molecular Biology, 63(1), 49–52. https://doi.org/10.14715/cmb/2017.63.1.10
Download Citation
Endnote/Zotero/Mendeley (RIS)
BibTeX
References
  1. Guerci B, Böhme P, Kearney-Schwartz A, Zannad F, Drouin P. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus. Diabetes Metab 2001; 27: 436–47.
  2. Resnick HE, Howard BV. Diabetes and cardiovascular disease. Annu Rev Med 2002; 53:245–67.
  3. Guariguataa L, Whitingb DR, Hambletonc I, Beagleya J, Linnenkampa U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103:137–49.
  4. Waugh N, Scotland G, Mcnamee P, Gillett M, Brennan A, Goyder E, et al. Screening for type 2 diabetes: literature review and economic modelling. Health Technol Assess 2007; 11:1-125,
  5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35:564–71.
  6. Dhananjayan R, Koundinya KS, Malati T, Kutala VK. Endothelial Dysfunction in Type 2 Diabetes Mellitus. Indian J Clin Biochem 2016; 31: 372-79.
  7. Levine AB, Punihaole D, Levine TB. Characterization of the role of nitric oxide and its clinical applications. Cardiology 2012; 122:55-68.
  8. Schmiidt HHHW, Walter U. NO at work. Cell 1994; 78:919-25.
  9. Tessari P, Cecchet D, Cosma A, Vettore M, Coracina A, Millioni R, et al. Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes 2010; 59:2152-9.
  10. Zhang Y, Xiao HQ, Zeng XT, Zuo HX, Xu YC. Associations between endothelial nitric oxide synthase polymorphisms and risk of diabetic nephropathy: an updated meta-analysis. Ren Fail 2015; 37:312-26.
  11. Snyder SH, Bredt DS. Nitric oxide as a neuronal messenger. Trends Pharmacol Sci 1991; 12:125-8.
  12. Lowenstein CJ, Snyder SH. Nitric oxide, a novel biological messenger. Cell 1992; 70:705-7.
  13. Pal P, Joseph SB, Lucas L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007; 87:315–424.
  14. Hung LM, Huang JP, Liao JM, Yang MH, Li DE, Day YJ, et al. Insulin renders diabetic rats resistant to acute ischemic stroke by arresting nitric oxidereaction with superoxide to form peroxynitrite. J Biomed Sci 2014; 21:92.
  15. Galen MP. Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 1998; 31:1047–60.
  16. Maejima K, Nakano S, Himeno M, Tsuda S, Makiishi H, Ito T, et al. Increased basal levels of plasma nitric oxide in Type 2 diabetic subjects. Relationship to microvascular complications. J Diabetes Complications 2001; 15:135-43.
  17. Son SM. Reactive oxygen and nitrogen species in pathogenesis of vascular complications of diabetes. Diabetes Metab J. 2012; 36:190-8.
  18. Caimi G, Hopps E, Montana M, Noto D, Canino B, Lo Presti R, et al. Evaluation of nitric oxide metabolites in a group of subjects with metabolic syndrome. Diabetes Metab Syndr 2012; 6:132-5.
  19. Caimi G, Hopps E, Montana M, Carollo C, Calandrino V, Incalcaterra E, et al. Nitric oxide metabolites (nitrite and nitrate) in several clinical condition. Clin Hemorheol Microcirc 2014; 56:359-69.
  20. Cai S, Khoo J, Channon KM. Augmented BH4 by gene transfer restores nitric oxide synthase function in hyperglycemic human endothelial cells. Cardiovascular Research 2005; 65:823–31.
  21. Yang P, Cao Y, Hua LI. Hyperglycemia induces iNOS gene expression and consequent nitrosative stress via JNK activation. Am J Obstet Gynecol 2010; 203:185.
  22. Balletshofer BM, Rittig K, Enderle MD, Volk A, Maerker E, Jacob S, et al. Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 2000; 101:1780-4.
  23. Bloomgarden ZT. American Diabetes Association Annual Meeting, 1999: insülin action and the development of type 2 diabetes. Diabetes Care 2000; 23:248-52.
  24. Chien WY, Yang KD, Eng HL, Hu YH, Lee PY, Wang STet al. Increased plasma concentration of nitric oxide in type 2 diabetes but not in non diabetic individuals with insulin resistance. Diabetes Metab 2005; 31:63-8.
  25. Amrita G, Mingma LS, Yazum B, Ranabir P, Sanjay D. Serum nitric oxide status in patients with type 2 diabetes in Sikkim. Int J Appl Basic Med Res 2011; 1:31-5.
  26. Francesco C, Keiichi H, Zvonimir SK. High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997; 96:25-8.
  27. Ishii N, Patel KP, Lane PH, Taylor T, Bian K, Murad F, et al. Nitric oxide synthesis and oxidative stress in the renal cortex of rats with diabetes mellitus. J Am Soc Nephrol 2001; 12:1630-9.
  28. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S. Endothelial dysfunction as a target for prevention of cardiovascular disease. Diab Care 2009; 32:314-21.
Read More

Author Biographies

O. Ozcelik, Firat University, Faculty of Medicine, Department of Physiology
Physiology
S. Algul, Yuzuncu Yil University, Faculty of Medicine, Department of Physiology
Physiology
Crossref
Scopus
Google Scholar
Europe PMC
Download this PDF file
PDF
Statistic
Read Counter : 956 Download : 356